Kevin M. Lalande, Director at LUMOS PHARMA, INC. (LUMO), bought 93,740 shares at $8.47 ($809K) on 2021-08-17, disclosed to the SEC on 2021-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.47 | 16,000 | $136K | 16.8% |
| 2 | $8.73 | 28,870 | $252K | 31.2% |
| 3 | $8.73 | 28,870 | $252K | 31.2% |
| 4 | $8.45 | 20,000 | $169K | 20.9% |
| Total | $8.63 avg | 93,740 | $809K | 100% |
| Filing → |
| LUMO | BUY | 2021-09-07 | $274K | — | Filing → |
| LUMO | BUY | 2021-09-01 | $269K | — | Filing → |
| LUMO | BUY | 2021-08-27 | $314K | — | Filing → |